Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, Najat Khan, Ph.D., will present Tuesday, January 13 ...
His job is to reimagine the future of drugmaking using that similarly trendy branch of computer science, artificial ...
Researchers identified a major decline in neural activity and retention when students used AI for writing. We need to empower ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ranks among the best AI stocks to buy according to analysts. On December 17, ...
Eli Lilly is a safer way to capitalize on AI-driven drug discovery.
A 13-year-old and his teen sister picked up vibe coding and ended up competing together in a 24-hour hackathon with their dad ...
Here are the top 16 conferences to mark on your 2026 calendar for technologists, business leaders, policy experts, and those ...
One of the key learning outcomes of university education in general, and liberal arts programmes, in particular, is that ...
The year 2025 marked a major leap for AI in health care, with breakthroughs in drug discovery, diagnostics, genomics and ...
This school year, all California State University students were given access to an educational version of ChatGPT, a ...
Takeda regains a majority of XOMA Royalty’s royalty interest in mezagitamab (TAK-079) –– XOMA Royalty will be entitled to payments based on a ...
Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) is one of the AI stocks under $20 to buy now. On December 8, Recursion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback